Literature DB >> 19815695

Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent.

Lisa Kalman1, Jean Amos Wilson, Arlene Buller, John Dixon, Lisa Edelmann, Louis Geller, William Edward Highsmith, Leonard Holtegaard, Ruth Kornreich, Elizabeth M Rohlfs, Toby L Payeur, Tina Sellers, Lorraine Toji, Kasinathan Muralidharan.   

Abstract

Many recessive genetic disorders are found at a higher incidence in people of Ashkenazi Jewish (AJ) descent than in the general population. The American College of Medical Genetics and the American College of Obstetricians and Gynecologists have recommended that individuals of AJ descent undergo carrier screening for Tay Sachs disease, Canavan disease, familial dysautonomia, mucolipidosis IV, Niemann-Pick disease type A, Fanconi anemia type C, Bloom syndrome, and Gaucher disease. Although these recommendations have led to increased test volumes and number of laboratories offering AJ screening, well-characterized genomic reference materials are not publicly available. The Centers for Disease Control and Prevention-based Genetic Testing Reference Materials Coordination Program, in collaboration with members of the genetic testing community and Coriell Cell Repositories, have developed a panel of characterized genomic reference materials for AJ genetic testing. DNA from 31 cell lines, representing many of the common alleles for Tay Sachs disease, Canavan disease, familial dysautonomia, mucolipidosis IV, Niemann-Pick disease type A, Fanconi anemia type C, Bloom syndrome, Gaucher disease, and glycogen storage disease, was prepared by the Repository and tested in six clinical laboratories using three different PCR-based assay platforms. A total of 33 disease alleles was assayed and 25 different alleles were identified. These characterized materials are publicly available from Coriell and may be used for quality control, proficiency testing, test development, and research.

Entities:  

Mesh:

Year:  2009        PMID: 19815695      PMCID: PMC2765751          DOI: 10.2353/jmoldx.2009.090050

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  31 in total

Review 1.  Molecular basis of mendelian disorders among Jews.

Authors:  J Zlotogora; G Bach; A Munnich
Journal:  Mol Genet Metab       Date:  2000-03       Impact factor: 4.797

2.  Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.

Authors:  Lisa Edelmann; Jianli Dong; Robert J Desnick; Ruth Kornreich
Journal:  Am J Hum Genet       Date:  2002-02-13       Impact factor: 11.025

3.  Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.

Authors:  Leah Peleg; Rachel Pesso; Boleslaw Goldman; Keren Dotan; Merav Omer; Eitan Friedman; Michal Berkenstadt; Haike Reznik-Wolf; Gad Barkai
Journal:  Isr Med Assoc J       Date:  2002-02       Impact factor: 0.892

Review 4.  Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.

Authors:  C M Eng; R J Desnick
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

5.  Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies.

Authors:  J C Beck; C M Beiswanger; E M John; E Satariano; D West
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

6.  Development of genomic reference materials for cystic fibrosis genetic testing.

Authors:  Victoria M Pratt; Michele Caggana; Christina Bridges; Arlene M Buller; Lisa DiAntonio; W Edward Highsmith; Leonard M Holtegaard; Kasinathan Muralidharan; Elizabeth M Rohlfs; Jack Tarleton; Lorraine Toji; Shannon D Barker; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-04-09       Impact factor: 5.568

7.  Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.

Authors:  R Bargal; N Avidan; T Olender; E Ben Asher; M Zeigler; A Raas-Rothschild; A Frumkin; O Ben-Yoseph; Y Friedlender; D Lancet; G Bach
Journal:  Hum Mutat       Date:  2001-05       Impact factor: 4.878

8.  Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.

Authors:  L Edelmann; M P Wasserstein; R Kornreich; C Sansaricq; S E Snyderman; G A Diaz
Journal:  Am J Hum Genet       Date:  2001-08-16       Impact factor: 11.025

Review 9.  Quality assurance in human molecular genetics testing: status and recommendations.

Authors:  Laurina O Williams; Eugene C Cole; Ira M Lubin; Norma I Iglesias; Ruth L Jordan; Lauren E Elliott
Journal:  Arch Pathol Lab Med       Date:  2003-10       Impact factor: 5.534

10.  Laboratory standards and guidelines for population-based cystic fibrosis carrier screening.

Authors:  W W Grody; G R Cutting; K W Klinger; C S Richards; M S Watson; R J Desnick
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822

View more
  6 in total

1.  Chromosomal variation in lymphoblastoid cell lines.

Authors:  Matthew D Shirley; Joseph D Baugher; Eric L Stevens; Zhenya Tang; Norman Gerry; Christine M Beiswanger; Dorit S Berlin; Jonathan Pevsner
Journal:  Hum Mutat       Date:  2012-04-16       Impact factor: 4.878

2.  Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.

Authors:  Shannon D Barker; Sherri Bale; Jessica Booker; Arlene Buller; Soma Das; Kenneth Friedman; Andrew K Godwin; Wayne W Grody; Edward Highsmith; Jeffery A Kant; Elaine Lyon; Rong Mao; Kristin G Monaghan; Deborah A Payne; Victoria M Pratt; Iris Schrijver; Antony E Shrimpton; Elaine Spector; Milhan Telatar; Lorraine Toji; Karen Weck; Barbara Zehnbauer; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-09-18       Impact factor: 5.568

3.  Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.

Authors:  Stuart A Scott; Lisa Edelmann; Liu Liu; Minjie Luo; Robert J Desnick; Ruth Kornreich
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

4.  Bridging the gap: moving predictive and prognostic assays from research to clinical use.

Authors:  P Michael Williams; Tracy G Lively; J Milburn Jessup; Barbara A Conley
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

5.  Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods.

Authors:  Chih-Jian Lih; Han Si; Biswajit Das; Robin D Harrington; Kneshay N Harper; David J Sims; Paul M McGregor; Corinne E Camalier; Andrew Y Kayserian; P Mickey Williams; Hua-Jun He; Jamie L Almeida; Steve P Lund; Steve Choquette; Kenneth D Cole
Journal:  J Mol Diagn       Date:  2016-07-25       Impact factor: 5.568

Review 6.  Development and Characterization of Reference Materials for Genetic Testing: Focus on Public Partnerships.

Authors:  Lisa V Kalman; Vivekananda Datta; Mickey Williams; Justin M Zook; Marc L Salit; Jin Yeong Han
Journal:  Ann Lab Med       Date:  2016-11       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.